ACAD

ACADIA Pharmaceuticals Inc

ACADIA Pharmaceuticals Inc is a biopharmaceutical company that specializes in developing and commercializing innovative medicines to address unmet medical needs in central nervous system disorders. Their flagship product, NUPLAZID, is the first and only FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis. ACADIA is also working on a pipeline of product candidates for other neurological and psychiatric disorders, such as dementia-related psychosis, schizophrenia, and major depressive disorder. The company is dedicated to advancing science and improving the lives of patients and their families affected by these debilitating diseases. ACADIA is headquartered in San Diego, California, and has operations in the United States and Europe.

Instrument specification in OANDA

Name
Currency
Symbol
Minimum order value
Ticker
Trading hours
Type
Hours of accepting orders
ISIN

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top